Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir for HBV Reactivation After Hepatectomy in HBV-DNA Negative HCC
NCT02829359Phase 3Completed
- Sponsor
- Guangxi Medical University
- Start
- Jul 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of entecavir in hepatitis B virus infection, sponsored by Guangxi Medical University. Started Jul 2012; status: completed.
02
Drugs
entecavir
03
Conditions
hepatitis B virus infection
Beyond the preview
Go deeper on NCT02829359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829359.